These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
30. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents. Jacobs SE; Jacobs JL; Dennis EK; Taimur S; Rana M; Patel D; Gitman M; Patel G; Schaefer S; Iyer K; Moon J; Adams V; Lerner P; Walsh TJ; Zhu Y; Anower MR; Vaidya MM; Chaturvedi S; Chaturvedi V Antimicrob Agents Chemother; 2022 Jul; 66(7):e0005322. PubMed ID: 35770999 [TBL] [Abstract][Full Text] [Related]
31. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris. Iyer KR; Camara K; Daniel-Ivad M; Trilles R; Pimentel-Elardo SM; Fossen JL; Marchillo K; Liu Z; Singh S; Muñoz JF; Kim SH; Porco JA; Cuomo CA; Williams NS; Ibrahim AS; Edwards JE; Andes DR; Nodwell JR; Brown LE; Whitesell L; Robbins N; Cowen LE Nat Commun; 2020 Dec; 11(1):6429. PubMed ID: 33353950 [TBL] [Abstract][Full Text] [Related]
32. Confirmation of fifth Spruijtenburg B; Badali H; Abastabar M; Mirhendi H; Khodavaisy S; Sharifisooraki J; Taghizadeh Armaki M; de Groot T; Meis JF Emerg Microbes Infect; 2022 Dec; 11(1):2405-2411. PubMed ID: 36154919 [No Abstract] [Full Text] [Related]
34. Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles. Fayed B; Jayakumar MN; Soliman SSM Med Mycol; 2021 Dec; 59(12):1243-1256. PubMed ID: 34612496 [TBL] [Abstract][Full Text] [Related]
35. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol. Srivastava V; Ahmad A PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266 [TBL] [Abstract][Full Text] [Related]
36. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
37. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates]. Gulat S; Doluca Dereli M Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270 [TBL] [Abstract][Full Text] [Related]
38. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970 [TBL] [Abstract][Full Text] [Related]
39. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait. Al-Baqsami ZF; Ahmad S; Khan Z Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126 [TBL] [Abstract][Full Text] [Related]
40. A Transcriptomics Approach To Unveiling the Mechanisms of Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]